DYEE Capital (德屹资本) is a venture capital and private equity firm founded in 2016 and headquartered in Xiamen, China, with a branch in Shanghai. The firm invests across a diversified range of industries including healthcare, consumer discretionary, financial services, information technology, and TMT, focusing on venture and growth opportunities.
40% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-a (40% of deals). Average disclosed round size is $63.8M (across 5 rounds with reported amounts).
Portfolio
5
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
DZ
Dezhen Zhu
Founder, Chairman and Managing Partner
SC
Swing Chen
Partner
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| DDegron Therapeutics | Series A | $22M | Jun 2022 |
| GGenFleet | Series C | $75M | Dec 2021 |
| IIONOVA Life Science | Unknown | $100M | Aug 2021 |
 Elpiscience | Series C | $105M | May 2021 |
 Ionova | Series A | $17M | Jan 2019 |
Top Co-Investors
LAV3 shared
Baidu Ventures2 shared
Lilly Asia Ventures2 shared
Shenzhen Capital Group1 shared
Next Capital1 shared
Med-Fine Capital1 shared
Icon Ventures1 shared
YuanBio Venture Capital1 shared
Cormorant Asset Management1 shared
Oriza1 shared
CDH Investments1 shared
HighLight Capital1 shared
Lake Bleu Capital1 shared
Last updated: 8 September 2026